ArticleActa bio-medica : Atenei Parmensis2021
Italian National Recovery and Resilience Plan: a Healthcare Renaissance after the COVID-19 crisis?
Article in Acta bio-medica : Atenei Parmensis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Proximity care pathways and digitalization: opportunities and concerns for medication safety management-Insights from the ProSafe study on community perspectives.Frontiers in public health · 2025Article
- A new organizational model of primary healthcare in Liguria, Italy. Insights and implications.Journal of preventive medicine and hygiene · 2024Article
- Correlation between relative age-standardized mortality rates and COVID-19 mortality over time in Italy.Acta bio-medica : Atenei Parmensis · 2023Article
- Rapid evidence review: Policy actions for the integration of public health and health care in the United States.Frontiers in public health · 2023Review
- Revising the legislation of Ethics Committees to ease biomedical research in humans across the world: lessons from the COVID-19 emergency.Acta bio-medica : Atenei Parmensis · 2022Article
- COVID-19: yesterday, today and tomorrow. The quality of COVID-19 management and the evaluation of the "Health" chapter of the Recovery Plan.Journal of preventive medicine and hygiene · 2022Review
- Approaches to priority identification in digital health in ten countries of the Global Digital Health Partnership.Frontiers in digital health · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proposed for the first time by European Commission in May 2020, the "NextGenerationEU" (NGEU) program is the European Union's most important effort to address key issues relating to public health and healthcare, digital and technological innovation, climate change, sustainable mobility, and key sociocultural aspects. In addition, the NGEU represents a response to the COVID-19 crisis through an extremely powerful financial intervention (over 800 billion euros). Italy is one of the main recipients of the NGEU plan's resources with almost 200 billion euros received in grants and loans. Implementation of the NGEU in Italy will take place through the National Recovery and Resilience Plan (NRRP). The NRRP not only describes how the NGEU resources will be used, but it singles out crucial public law reforms in national legislation and organization. Unsurprisingly, public health intervention represents a major component of the NRRP. Here we summarize and discuss the rules, regulations and perspective envisaged by the NRRP to foster effective healthcare and to reshape the Italian National Health System through the redesigning of primary care, enhanced communication between hospital and community healthcare, and stronger implementation of digital technologies in public health. (www.actabiomedica.it).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.